Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACRU | Preferred Stock | Other | -1M | -50% | 1M | Oct 1, 2021 | Common Stock | 30M | By DR Shell LLC | F1, F2, F3 | |||
transaction | ACRU | Series A Preferred Stock | Other | +125K | 125K | Oct 1, 2021 | Common Stock | 62.4M | By DR Shell LLC | F2, F4, F5 |
Id | Content |
---|---|
F1 | Each share of Preferred Stock converts into 30 shares of common stock. |
F2 | Pursuant to a reclassification exempt under Rule 16b-7, 10,000,000 shares of Preferred Stock were reclassified into and exchanged for 3,094,503.43 shares of Series A Preferred Stock. |
F3 | The Reporting Person retained 1,000,000 shares of Preferred Stock in connection with the Share Exchange Agreement dated August 12, 2021, between the Issuer, Mikab Corporation, the shareholders of Mikab and DR Shell LLC. |
F4 | Each share of Series A Preferred Stock converts into 500 shares of common stock, subject to customary adjustments. |
F5 | The Series A Preferred Stock has no expiration date, except that it will be automatically converted immediately upon the effectiveness of a one-for-100 reverse stock split of the Issuer's issued and outstanding common stock. |